Syncing versus linking: A patient’s clinical trial journey
As precision medicines and highly individualized therapies become more common, patients are...
As precision medicines and highly individualized therapies become more common, patients are...
The therapeutic market that you know is shaped by the healthcare data that you can see. But when critical medical, specialty, clinical or longitudinal signals are absent from that view, the picture (and the decisions based on it) is less clear.